INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 410m ago
House PTR10m ago
SEC 13F9m ago
Robinhood Chain9m ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,432 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M$55.8
90 sh
Jan 28, 2026
Page 1374 of 1786
← PrevNext →
Jan 30, 2026
traded Jan 28, 2026
+2d
SEC Form 4

Evidence

5
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
1,925 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

5
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
11.8K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

5
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

5
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
18.1K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

5
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Grant or award
A—
9,000 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

5
BM
Brosius MarkSVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Grant or award
A—
5,585 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

5
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
1,925 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$6,159
50 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$35K
300 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$6,159
50 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$35K
300 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

0
CM
Curet MyriamEVP & Chief Medical Officer
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M$26K
126 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

0
CM
Curet MyriamEVP & Chief Medical Officer
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
126 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

0
CM
Curet MyriamEVP & Chief Medical Officer
ISRGINTUITIVE SURGICAL INC
Grant or award · 10b5-1 plan
A—
5,585 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

53
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$629K
677 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

49
Solomon David MDirector, Chairman of the Board and CEO
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$218K
232 sh
Jan 29, 2026Jan 29, 2026
traded Jan 29, 2026
+0dSEC Form 4

Evidence

49
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$676K
728 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

49
FC
Fleming Allysun CExecutive Vice President
CMACOMERICA INC
Open-market sale
SELL$837K
8,864 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

46
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$217K
235 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

46
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$156K
168 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

46
Solomon David MDirector, Chairman of the Board and CEO
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$38K
40 sh
Jan 29, 2026Jan 29, 2026
traded Jan 29, 2026
+0dSEC Form 4

Evidence

42
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$158K
171 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

42
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$145K
157 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

42
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$103K
112 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

42
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$179K
193 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

42
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$86K
92 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

42
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$200K
216 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

42
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$79K
85 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

41
TC
Trabuco CarolynDirector
USARUSA Rare Earth, Inc.
Open-market purchase
BUY$29K
1,300 sh
Jan 29, 2026Jan 29, 2026
traded Jan 29, 2026
+0dSEC Form 4

Evidence

39
HC
Halio CareyGlobal Treasurer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$11K
12 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

38
JR
Jeffrey John Ronald Jr.Director
AGXARGAN INC
Open-market sale
SELL$1.80M
5,000 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

36
BM
Butler Amy MEVP, NATIONAL SALES
NPBNORTHPOINTE BANCSHARES INC
Open-market sale
SELL$123K
6,800 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

32
BM
Butler Amy MEVP, NATIONAL SALES
NPBNORTHPOINTE BANCSHARES INC
Open-market sale
SELL$111K
6,365 sh
Jan 29, 2026Jan 29, 2026
traded Jan 29, 2026
+0dSEC Form 4

Evidence

31
LB
Luciani BarryEVP
FMFGFarmers & Merchants Bancshares, Inc.
Grant or award
A—
1,200 sh
Jan 21, 2026Jan 29, 2026
traded Jan 21, 2026
+8dSEC Form 4

Evidence

30
HD
Hahnfeld Jeffrey DEVP-CONTROLLER & CHIEF ACC OFF
WTFCWINTRUST FINANCIAL CORP
Open-market sale
SELL$46K
314 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

29
CP
Coleman Denis P.Chief Financial Officer
GSGOLDMAN SACHS GROUP INC
Tax withholding
F$12.09M
13.0K sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

29
CR
Cabrera Phillip R.Director
BYBYLINE BANCORP, INC.
Open-market purchase
BUY$5,244
169 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence